| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 22.790 | 25.257 | 25.775 | 22.373 | 26.102 | 36.804 | 37.124 | 36.111 | 30.277 |
| Total Income - EUR | - | 22.790 | 25.257 | 25.775 | 22.373 | 26.102 | 47.680 | 37.713 | 36.554 | 30.307 |
| Total Expenses - EUR | - | 718 | 1.355 | 627 | 4.078 | 16.422 | 14.910 | 20.543 | 26.499 | 26.763 |
| Gross Profit/Loss - EUR | - | 22.072 | 23.902 | 25.148 | 18.294 | 9.680 | 32.769 | 17.170 | 10.055 | 3.544 |
| Net Profit/Loss - EUR | - | 21.388 | 23.144 | 24.375 | 17.749 | 9.295 | 31.531 | 16.313 | 9.701 | 2.654 |
| Employees | - | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Imag Cic Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 846 | 650 | 460 | 10.831 | 7.751 | 45.137 | 33.405 | 22.510 | 13.058 |
| Current Assets | - | 20.823 | 22.778 | 24.663 | 25.289 | 21.551 | 19.152 | 16.993 | 13.904 | 9.437 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.216 | 1.862 | 1.154 | 1.833 | 2.323 | 4.965 | 13.323 | 11.435 | 3.450 |
| Cash | - | 18.607 | 20.916 | 23.510 | 23.457 | 19.227 | 14.187 | 3.671 | 2.470 | 5.987 |
| Shareholders Funds | - | 21.433 | 23.197 | 24.427 | 26.397 | 24.581 | 36.412 | 16.362 | 9.750 | 2.702 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 236 | 231 | 696 | 9.723 | 4.721 | 27.876 | 34.037 | 26.665 | 19.792 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Imag Cic Med Srl